Targeting CD38 immunometabolic checkpoint improves metabolic fitness and cognition in a mouse model of Alzheimer's disease.Published in:Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-58494-yBy:Peralta Ramos, Javier María;Castellani, Giulia;Kviatcovsky, Denise;Croese, Tommaso;Tsitsou-Kampeli, Afroditi;Burgaletto, Chiara;Abellanas, Miguel Angel;Cahalon, Liora;Phoebeluc Colaiuta, Sarah;Salame, Tomer-Meir;Kuperman, Yael;Savidor, Alon;Itkin, Maxim;Malitsky, Sergey;Ovadia, Sharon;Ferrera, Shir;Kalfon, Limor;Kadmani, Shiran;Samra, Nadra;Paz, RotemPublication type:Article